Balyasny Asset Management »

Phathom Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $155k 15k 10.30
2022-09-30 $205k 19k 11.06

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Jennison Associates
Invesco
Carlyle
BlackRock
BlackRock
Ensign Peak Advisors
Woodline Partners
Vanguard Group
NEA Management Company
Avidity Partners Management
OrbiMed Advisors
Federated Investors
Decheng Capital

View all funds holding Phathom Pharmaceuticals